Arabic Arabic English English French French German German
dark

NeoDynamics receives first German order of pulse biopsy system NeoNavia

NeoDynamics AB, a MedTech company dedicated to advancing diagnosis and care of breast cancer, announced that the company has received the first German commercial order of its pulse biopsy system NeoNavia from Hermann-Josef-Hospital in Erkelenz, a teaching hospital of the University of Aachen, a reputed and certified breast centre. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Hansa Biopharma announces long term follow-up data demonstrating 3-year graft survival of 84% after imlifidase treatment and transplantation

Next Post

UK’s MHRA accepts Humanigen’s submission of Lenzilumab for Marketing Authorization in COVID-19 for expedited rolling review

Related Posts
Total
0
Share